← Back to Search

Spectroscopic photoacoustic imaging for Breast Cancer

N/A

Waitlist Available

Led By Roberta M. diFlorio-Alexander, MD

Research Sponsored by Geoff Luke

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Subjects are female age 18 or older with breast cancer and who will undergo surgical SLN biopsy/procedure or axillary dissection.

Subjects are capable of giving informed consent.

Timeline

Screening 3 weeks

Treatment Varies

Follow Up day 1, up to 12 weeks after imaging

Awards & highlights

Study Summary

This trial will test whether a new imaging device is better than the current standard at detecting early signs of cancer spread.

Eligible Conditions

Breast Cancer

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

You are female, 18 or older with breast cancer and will have a surgical lymph node biopsy/procedure or axillary dissection.

Select...

Subjects possess the capacity to provide informed consent.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ day 1, up to 12 weeks after imaging

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~day 1, up to 12 weeks after imaging

This trial's timeline: 3 weeks for screening, Varies for treatment, and day 1, up to 12 weeks after imaging for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Spectroscopic photoacoustic image acquisition feasibility

Secondary outcome measures

Spectroscopic photoacoustic image depth

Spectroscopic photoacoustic imaging device comparison

Trial Design

1Treatment groups

Experimental Treatment

Group I: Spectroscopic photoacoustic imagingExperimental Treatment1 Intervention

Any suspicious lymph nodes identified through ultrasound will be imaged with spectroscopic photoacoustic imaging, which is a diagnostic test to measure saturated oxygen in the nodes.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

Geoff LukeLead Sponsor

Dartmouth CollegeOTHER

79 Previous Clinical Trials

1,415,573 Total Patients Enrolled

4 Trials studying Breast Cancer

1,377,670 Patients Enrolled for Breast Cancer

Dartmouth-Hitchcock Medical CenterOTHER

524 Previous Clinical Trials

2,543,340 Total Patients Enrolled

28 Trials studying Breast Cancer

2,352,829 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there vacancies for participants in this trial?

"As recorded on clinicaltrials.gov, this investigation is no longer recruiting patients and has not been since March 21st 2022 when the post was last updated. Despite this study being inactive now, there are still 2603 other trials actively seeking participants at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Photoacoustic Lymph Node Imaging

Geoff Luke 2019. "Photoacoustic Lymph Node Imaging". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03931655.